undamentalytics Newsletter
Sign in

Usana Health Sciences Inc cash flow statement

In fiscal 2025, Usana Health Sciences Inc's operations generated $22.3m of cash; it spent $13.8m on capital projects, leaving free cash flow of $8.5m. It returned $27.5m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jan 20102010Jan 20112011Dec 20112012Dec 20122013Dec 20132014Jan 20152015Jan 20162016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Jan 20212021Jan 20222022Dec 20222023Dec 20232024Dec 20242025Jan 2026LTMJul 2026
Cash from operations326670939910511113712415212716012110471612228
Depreciation and amortisation788999101316171514131313153332
Stock-based pay9101110810111715151614141315151414
Capital spending44118820243313111715131014101412
Free cash flow28625984918588104111141110145108945651916
Free cash flow after stock pay1952497483757788951269513194804236−52
Share buybacks2173368181396165501051505717825129280

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: ODD vs USNANUS vs USNAIPAR vs USNANATR vs USNA

More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies

Figures from Usana Health Sciences Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Usana Health Sciences Inc.